These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 15531223)
1. Effects of the combined continuous administration of morphine and the high-efficacy 5-HT1A agonist, F 13640 in a rat model of trigeminal neuropathic pain. Deseure KR; Adriaensen HF; Colpaert FC Eur J Pain; 2004 Dec; 8(6):547-54. PubMed ID: 15531223 [TBL] [Abstract][Full Text] [Related]
2. Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain. Deseure K; Koek W; Adriaensen H; Colpaert FC J Pharmacol Exp Ther; 2003 Aug; 306(2):505-14. PubMed ID: 12730352 [TBL] [Abstract][Full Text] [Related]
4. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist. Deseure K; Bréand S; Colpaert FC Eur J Pharmacol; 2007 Jul; 568(1-3):134-41. PubMed ID: 17512927 [TBL] [Abstract][Full Text] [Related]
5. Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model: a c-Fos study. Buritova J; Larrue S; Aliaga M; Besson JM; Colpaert F Eur J Pharmacol; 2005 May; 514(2-3):121-30. PubMed ID: 15910798 [TBL] [Abstract][Full Text] [Related]
7. The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes. You HJ; Colpaert FC; Arendt-Nielsen L Exp Neurol; 2005 Jan; 191(1):174-83. PubMed ID: 15589524 [TBL] [Abstract][Full Text] [Related]
8. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters. Bardin L; Assié MB; Pélissou M; Royer-Urios I; Newman-Tancredi A; Ribet JP; Sautel F; Koek W; Colpaert FC J Pharmacol Exp Ther; 2005 Mar; 312(3):1034-42. PubMed ID: 15528450 [TBL] [Abstract][Full Text] [Related]
9. Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia. Colpaert FC; Tarayre JP; Koek W; Pauwels PJ; Bardin L; Xu XJ; Wiesenfeld-Hallin Z; Cosi C; Carilla-Durand E; Assié MB; Vacher B Neuropharmacology; 2002 Nov; 43(6):945-58. PubMed ID: 12423664 [TBL] [Abstract][Full Text] [Related]
10. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Carey RJ; DePalma G; Damianopoulos E; Shanahan A; Müller CP; Huston JP Brain Res; 2005 Feb; 1034(1-2):162-71. PubMed ID: 15713268 [TBL] [Abstract][Full Text] [Related]
11. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence. Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913 [TBL] [Abstract][Full Text] [Related]
12. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief. Colpaert FC Curr Opin Investig Drugs; 2006 Jan; 7(1):40-7. PubMed ID: 16425670 [TBL] [Abstract][Full Text] [Related]
13. Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. Nielsen CK; Lewis RJ; Alewood D; Drinkwater R; Palant E; Patterson M; Yaksh TL; McCumber D; Smith MT Pain; 2005 Nov; 118(1-2):112-24. PubMed ID: 16154696 [TBL] [Abstract][Full Text] [Related]
14. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo. Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781 [TBL] [Abstract][Full Text] [Related]
15. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. de Boer SF; Koolhaas JM Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183 [TBL] [Abstract][Full Text] [Related]
16. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates. Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004 [TBL] [Abstract][Full Text] [Related]
17. The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain. Kiss I; Degryse AD; Bardin L; Gomez de Segura IA; Colpaert FC Eur J Pharmacol; 2005 Oct; 523(1-3):29-39. PubMed ID: 16226246 [TBL] [Abstract][Full Text] [Related]
18. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats. Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929 [TBL] [Abstract][Full Text] [Related]
19. Eye-wiping test: a sensitive animal model for acute trigeminal pain studies. Farazifard R; Safarpour F; Sheibani V; Javan M Brain Res Brain Res Protoc; 2005 Dec; 16(1-3):44-9. PubMed ID: 16307902 [TBL] [Abstract][Full Text] [Related]
20. The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain. Deseure K; Koek W; Colpaert FC; Adriaensen H Eur J Pharmacol; 2002 Dec; 456(1-3):51-7. PubMed ID: 12450569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]